跳至主要内容
临床试验/DRKS00011840
DRKS00011840招募中不适用

Influence of inflammatory processes during radiotherapy on circulating epithelial tumor cells (CETC) and the formation of tumorspheres, as well as the effect of non-steroidal anti-inflammatory drugs (NSAID) on the growth behavior of tumorspheres

Transfusionsmedizinisches Zentrum Bayreuth, Labor Dr. Pachmann Bayreuth0 个研究点目标入组 100 人开始时间: 2017年4月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • histologically confirmed invasive breast carcinoma
  • age >= 18 years
  • exclusive treatment at the Jena University Hospital
  • Complete curative-intended adjuvant or definite radiotherapy (achieved total dose = 50 Gy normo- or hypofraction)
  • at least 3 blood samples (before the start of therapy, half of the fractions, after the end of RT, 6 weeks after the end of RT)
  • Dose concepts:
  • Hypofraction up to 42.56 (2.66) Gy, normofraction to 50.0 (2.0) Gy followed by a boost up to 16.0 Gy, 5 Fx / week

排除标准

  • Lack of willingness to consent
  • Presence of metastases
  • Recurrence
  • DCIS, inflammatory breast carcinoma
  • Second malignancy <10 years before diagnosis of breast cancer
  • Radiation therapy in anamnesis

研究者

发起方
Transfusionsmedizinisches Zentrum Bayreuth, Labor Dr. Pachmann Bayreuth

相似试验